Matilda Appelgren

Artiklar

Article: BREAST. 2022;63:16-23

Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial.

Appelgren M; Sackey H; Wengström Y; Johansson K; Ahlgren J; Andersson Y; Bergkvist L; Frisell J; Lundstedt D; Rydén L; Sund M; Alkner S; Vrou Offersen B; Filtenborg Tvedskov T; Christiansen P; de Boniface J; SENOMAC Trialists' Group
Article: BJS OPEN. 2021;5(1):zraa013

Recurrence and survival after standard versus oncoplastic breast-conserving surgery for breast cancer.

André C; Holsti C; Svenner A; Sackey H; Oikonomou I; Appelgren M; Johansson ALV; de Boniface J

Review: CANCERS. 2021;13(7):1565

Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study.

Banys-Paluchowski M; Gasparri ML; de Boniface J; Gentilini O; Stickeler E; Hartmann S; Thill M; Rubio IT; Di Micco R; Bonci E-A; Niinikoski L; Kontos M; Karadeniz Cakmak G; Hauptmann M; Peintinger F; Pinto D; Matrai Z; Murawa D; Kadayaprath G; Dostalek L; Nina H; Krivorotko P; Classe J-M; Schlichting E; Appelgren M; Paluchowski P; Solbach C; Blohmer J-U; Kühn T; The Axsana Study Group